Common Sense Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $500K

Common Sense General Information

Description

Manufacturer of non-invasive diagnostic products for women designed to classify common abnormal vaginal discharges. The company's products use a testing technology that can be embedded into products, including panty liners, that assess for vaginal bacterial infections, as well as for amniotic-fluid leaks during the final phase of pregnancy, enabling women to track their health via color coding and act accordingly.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 7 Ha'Eshel, Zone 2 Caesarea Industrial Park
  • Caesarea 38900
  • Israel
Primary Industry
Diagnostic Equipment
Acquirer
Vertical(s)
Corporate Office
  • 7 Ha'Eshel, Zone 2 Caesarea Industrial Park
  • Caesarea 38900
  • Israel

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Common Sense Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 06-Oct-2021 $500K Completed Generating Revenue
3. Out of Business 01-Jan-2018 Cancelled Generating Revenue
2. Secondary Transaction - Private 01-Feb-2014 $5M Completed Generating Revenue
1. Early Stage VC $5M $5M Completed Generating Revenue
To view Common Sense’s complete valuation and funding history, request access »

Common Sense Patents

Common Sense Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2015283587-A1 Diagnostic composition for identifying amniotic fluid Active 01-Jul-2014
AU-2015283587-B2 Diagnostic composition for identifying amniotic fluid Active 01-Jul-2014
AU-2019204327-A1 Diagnostic composition for identifying amniotic fluid Active 01-Jul-2014
AU-2019204327-B2 Diagnostic composition for identifying amniotic fluid Active 01-Jul-2014
CA-2953886-A1 Diagnostic composition for identifying amniotic fluid Active 01-Jul-2014 A61L15/56
To view Common Sense’s complete patent history, request access »

Common Sense Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioMedical Innovations Management Venture Capital Minority
Fishman Group PE/Buyout Minority
Foriland Investments Venture Capital Minority
Israel Technology Partners Venture Capital Minority
Latartech Holdings Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Common Sense FAQs

  • When was Common Sense founded?

    Common Sense was founded in 1999.

  • Where is Common Sense headquartered?

    Common Sense is headquartered in Caesarea, Israel.

  • What industry is Common Sense in?

    Common Sense’s primary industry is Diagnostic Equipment.

  • Is Common Sense a private or public company?

    Common Sense is a Private company.

  • What is the current valuation of Common Sense?

    The current valuation of Common Sense is .

  • What is Common Sense’s current revenue?

    The current revenue for Common Sense is .

  • How much funding has Common Sense raised over time?

    Common Sense has raised $5M.

  • Who are Common Sense’s investors?

    BioMedical Innovations Management, Fishman Group, Foriland Investments, Israel Technology Partners, and Latartech Holdings are 5 of 7 investors who have invested in Common Sense.

  • When was Common Sense acquired?

    Common Sense was acquired on 06-Oct-2021.

  • Who acquired Common Sense?

    Common Sense was acquired by PEPTONIC Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process